CNBCModerna says RSV vaccine is 84% effective at preventing disease in older adultsJan 17, 2023Spencer KimballBy Spencer Kimballbookmark_bordersharemore_vert
ReutersModerna says RSV vaccine 84% effective at preventing symptoms in older adultsJan 17, 2023Leroy Leo & Patrick WingroveBy Leroy Leo & Patrick Wingrovebookmark_bordersharemore_vert
CNBCRSV vaccine: Moderna, Pfizer start a new FDA approval raceJan 18, 2023Eric RosenbaumBy Eric Rosenbaumbookmark_bordersharemore_vert
New AtlasModerna's mRNA RSV vaccine delivers impressive Phase 3 trial resultsJan 18, 2023Rich HaridyBy Rich Haridybookmark_bordersharemore_vert
CNETModerna's RSV Vaccine for Older Adults Joins Race for First ApprovalJan 18, 2023Jessica RendallBy Jessica Rendallbookmark_bordersharemore_vert